Indinavir
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Indinavir?
Summarize this article for a 10 year old
Indinavir (IDV; trade name Crixivan, made by Merck) is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV/AIDS. It is soluble white powder administered orally in combination with other antiviral drugs. The drug prevents protease from functioning normally. Consequently, HIV viruses cannot reproduce, causing a decrease in the viral load. Commercially sold indinavir is indinavir anhydrous, which is indinavir with an additional amine in the hydroxyethylene backbone. This enhances its solubility and oral bioavailability, making it easier for users to intake. It was synthetically produced for the purpose of inhibiting the protease in the HIV virus.[1]
Clinical data | |
---|---|
Trade names | Crixivan |
AHFS/Drugs.com | Monograph |
MedlinePlus | a696028 |
License data | |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | ~65% |
Protein binding | 60% |
Metabolism | Hepatic via CYP3A4 |
Elimination half-life | 1.8 ± 0.4 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
PDB ligand | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C36H47N5O4 |
Molar mass | 613.803 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Currently, it is not recommended for use in HIV/AIDS treatment due to its side effects. Furthermore, it is controversial for many reasons starting from its development to its usage.
It was patented in 1991 and approved for medical use in 1996.[2]